Related Experiment Video
Updated: Sep 29, 2026

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
Coexpression of hepatocyte growth factor and its receptor (c-met oncogene) in HGL4 glioblastoma cells
G Shiota1, H Kawasaki, T Nakamura
1Second Department of Internal Medicine, Tottori University School of Medicine, Yonago, Japan.
Abstract:
Many recent studies have shown that hepatocyte growth factor (HGF) is pleiotropic. Indeed, HGF has been reported to act as a mitogen and a morphogen as well as a mitogen. To evaluate the biological significance of HGF in many cell types of different origin, we tested 32 cell lines for expression of HGF mRNA. Of 32 cell lines, 6 lines expressed HGF mRNA. Two glioblastoma cell lines, HGL4 and U138, also expressed its specific receptor (c-met oncogene) mRNA. The conditioned media of HGL4 contained 3.7-fold higher HGF activity compared to FaONeO cells as a negative control. Recombinant HGF stimulated DNA synthesis of HGL4 cells in a dose-dependent manner. In addition, anti-HGF antibody inhibited DNA synthesis of these cells. These findings suggest that coexpression of HGF and c-met oncogene stimulates growth of HGL4 glioblastoma cells.
Related Concept Videos
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

